- Home
- TKLF vs EVAX Comparison
TKLF vs EVAX Comparison
Compare TKLF & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- EVAX
- Stock Information
- Founded
- TKLF 2006
- EVAX 2008
- Country
- TKLF Japan
- EVAX Denmark
- Employees
- TKLF N/A
- EVAX N/A
- Industry
- TKLF Other Specialty Stores
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TKLF Consumer Discretionary
- EVAX Health Care
- Exchange
- TKLF Nasdaq
- EVAX Nasdaq
- Market Cap
- TKLF 15.7M
- EVAX 15.1M
- IPO Year
- TKLF 2022
- EVAX 2021
- Fundamental
- Price
- TKLF $3.65
- EVAX $2.70
- Analyst Decision
- TKLF
- EVAX Strong Buy
- Analyst Count
- TKLF 0
- EVAX 2
- Target Price
- TKLF N/A
- EVAX $10.00
- AVG Volume (30 Days)
- TKLF 6.6K
- EVAX 90.1K
- Earning Date
- TKLF 07-10-2025
- EVAX 10-30-2025
- Dividend Yield
- TKLF N/A
- EVAX N/A
- EPS Growth
- TKLF N/A
- EVAX N/A
- EPS
- TKLF 1.57
- EVAX N/A
- Revenue
- TKLF $210,119,238.00
- EVAX $3,176,000.00
- Revenue This Year
- TKLF N/A
- EVAX N/A
- Revenue Next Year
- TKLF N/A
- EVAX N/A
- P/E Ratio
- TKLF $2.28
- EVAX N/A
- Revenue Growth
- TKLF 7.38
- EVAX 1042.45
- 52 Week Low
- TKLF $2.20
- EVAX $1.20
- 52 Week High
- TKLF $6.60
- EVAX $17.75
- Technical
- Relative Strength Index (RSI)
- TKLF 48.02
- EVAX 44.63
- Support Level
- TKLF $3.38
- EVAX $2.70
- Resistance Level
- TKLF $3.69
- EVAX $2.85
- Average True Range (ATR)
- TKLF 0.13
- EVAX 0.20
- MACD
- TKLF 0.00
- EVAX -0.06
- Stochastic Oscillator
- TKLF 58.70
- EVAX 20.45
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.